A COVID-19 vaccine in early November? 'Extremely unlikely, but not impossible': Warp Speed head Slaoui Healthcare jobs grew by 75K in August as industry recovers from job losses due to COVID-19 Roche nets FDA authorization for combination COVID-19 and flu test Pfizer, BioNTech 'quietly' usher a 5th COVID-19 jab into the clinic: analyst Google, Oxford study projects benefits to coronavirus-tracing smartphone apps, even at low levels of adoption 3 questions every pediatrician needs to ask during the return to school Biopharma roundup: AstraZeneca scores 5 Defense Department sites for U.S. phase 3; Johnson & Johnson's shot thwarts severe COVID-19 in hamster trial Healthcare roundup: Allina Health, Aetna launch campaign urging patients to seek needed care Independent, smaller hospitals will need to make tough choices to survive COVID-19 financial crisis: analysis Featured Story | By Eric Sagonowsky With COVID-19 vaccine hype intensifying each day—including this week, with new comments from Pfizer’s CEO—the head of the U.S. government’s research program said it's "extremely unlikely" a vaccine will be available in early November. read more |
| |
|---|
|
Top Stories By Robert King The healthcare industry's job market continued to recover by adding 75,000 jobs in August, as hospitals continued to add more jobs after losses due to COVID-19. read more By Conor Hale Roche announced the launch of its second COVID-19 diagnostic of the week after securing an FDA authorization for a test that detects the novel coronavirus as well as influenza A and B, as the pandemic is set to collide with the annual flu season. read more By Amirah Al Idrus BioNTech and partner Pfizer have been working on four vaccine candidates against COVID-19, snagging FDA fast-track tags for two of them and pushing one into a 30,000-patient phase 3 study. Now, the duo is adding a fifth shot on goal, slated to enter a phase 1/2 study this month. read more By Conor Hale A study from Google and epidemiology researchers at Oxford University found that digital contract tracing using a network of smartphones could potentially help stem the spread of the novel coronavirus, even if a relatively small number of people download the app. read more By Jacqueline Renfrow Although there is still so much that is unknown about COVID-19, physicians, especially pediatricians, have found themselves navigating an uncertain terrain of guiding parents through questions about going back to school safely. read more By Eric Sagonowsky, Angus Liu, Kyle Blankenship, Conor Hale, Fraiser Kansteiner The U.S. Defense Department will provide five sites for AstraZeneca's U.S. vaccine trial. Merck may push two vaccine hopefuls into human testing this year. CureVac could make vaccines at scale by the year's end, an investor said. Animal data show J&J's shot curbed severe disease. Plus, Russia's shot yielded promising data, and the Philippines may want in. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more By Robert King Independent hospitals must prepare to make drastic cuts and pursue strategic mergers in order to survive a cash crisis caused by the COVID-19 pandemic, a new report from Kaufman Hall said. read more |
